E for L Aim Public Company Limited - Asset Resilience Ratio
E for L Aim Public Company Limited (EFORL) has an Asset Resilience Ratio of 0.00% as of December 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of E for L Aim Public Company Limited to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2021)
This chart shows how E for L Aim Public Company Limited's Asset Resilience Ratio has changed over time. See E for L Aim Public Company Limited balance sheet independence to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down E for L Aim Public Company Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see EFORL market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ฿0.00 | 0% |
| Short-term Investments | ฿0.00 | 0% |
| Total Liquid Assets | ฿0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: E for L Aim Public Company Limited maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
E for L Aim Public Company Limited Industry Peers by Asset Resilience Ratio
Compare E for L Aim Public Company Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
China National Medicines Corp Ltd
SHG:600511 |
Medical Distribution | 0.04% |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368 |
Medical Distribution | 1.77% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
|
China National Accord Medicines Corp Ltd
SHE:200028 |
Medical Distribution | -1.21% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
Annual Asset Resilience Ratio for E for L Aim Public Company Limited (2009–2021)
The table below shows the annual Asset Resilience Ratio data for E for L Aim Public Company Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-12-31 | 0.00% | ฿0.00 ≈ $0.00 |
฿1.68 Billion ≈ $52.28 Million |
-- |
| 2020-12-31 | 0.01% | ฿148.00K ≈ $4.61K |
฿1.56 Billion ≈ $48.52 Million |
+0.00pp |
| 2019-12-31 | 0.01% | ฿148.00K ≈ $4.61K |
฿2.44 Billion ≈ $76.17 Million |
+0.00pp |
| 2018-12-31 | 0.00% | ฿146.00K ≈ $4.55K |
฿3.22 Billion ≈ $100.28 Million |
+0.00pp |
| 2017-12-31 | 0.00% | ฿144.00K ≈ $4.49K |
฿3.89 Billion ≈ $121.11 Million |
+0.00pp |
| 2016-12-31 | 0.00% | ฿142.00K ≈ $4.43K |
฿6.75 Billion ≈ $210.33 Million |
-0.28pp |
| 2015-12-31 | 0.28% | ฿20.73 Million ≈ $646.14K |
฿7.31 Billion ≈ $227.71 Million |
-1.63pp |
| 2014-12-31 | 1.91% | ฿140.78 Million ≈ $4.39 Million |
฿7.37 Billion ≈ $229.60 Million |
+1.31pp |
| 2013-12-31 | 0.61% | ฿5.10 Million ≈ $158.87K |
฿840.99 Million ≈ $26.21 Million |
+0.57pp |
| 2012-12-31 | 0.03% | ฿19.00K ≈ $592.21 |
฿60.86 Million ≈ $1.90 Million |
+0.02pp |
| 2011-12-31 | 0.01% | ฿19.00K ≈ $592.21 |
฿160.42 Million ≈ $5.00 Million |
+0.00pp |
| 2010-12-31 | 0.01% | ฿18.00K ≈ $561.04 |
฿191.26 Million ≈ $5.96 Million |
-0.16pp |
| 2009-12-31 | 0.17% | ฿537.46K ≈ $16.75K |
฿313.14 Million ≈ $9.76 Million |
-- |
About E for L Aim Public Company Limited
E for L Aim Public Company Limited, together with its subsidiaries, engages in the distribution of medical devices and equipment in Thailand, the United States, Europe, and Asia. The company offers medical devices, including patient and central monitor systems, defibrillator, automated external defibrillator, electrocardiographs, electroencephalogram, PSG system, and accessories and consumables, … Read more